APA (7th ed.) Citation

J, L., Y, C., Y, L., Z, L., S, H., M, D., . . . Y, P. (2026). The MIF-CD74 axis drives colorectal cancer via glycolytic reprogramming and is targeted by a novel small-molecule inhibitor. Cellular oncology (Dordrecht, Netherlands), 49(3), . https://doi.org/10.1007/s13402-026-01202-9

Chicago Style (17th ed.) Citation

J, Lou, Chen Y, Li Y, Liu Z, Hu S, Ding M, Qin J, Sun H, and Pan Y. "The MIF-CD74 Axis Drives Colorectal Cancer via Glycolytic Reprogramming and Is Targeted by a Novel Small-molecule Inhibitor." Cellular Oncology (Dordrecht, Netherlands) 49, no. 3 (2026). https://doi.org/10.1007/s13402-026-01202-9.

MLA (9th ed.) Citation

J, Lou, et al. "The MIF-CD74 Axis Drives Colorectal Cancer via Glycolytic Reprogramming and Is Targeted by a Novel Small-molecule Inhibitor." Cellular Oncology (Dordrecht, Netherlands), vol. 49, no. 3, 2026, https://doi.org/10.1007/s13402-026-01202-9.